Clinical study of DAV + IFN-β therapy (combination adjuvant therapy with intravenous DTIC, ACNU and VCR, and local injection of IFN-β) for malignant melanoma

International Journal of Immunotherapy

Volumn 12, Issue 3-4, 1996, Pages 73-78

  Yamamoto, A ^a   Ishihara, K ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA INTERFERON; DACARBAZINE; NIMUSTINE;

ADJUVANT CHEMOTHERAPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE; MAJOR CLINICAL STUDY; MELANOMA;

EID: 0030389861     PISSN: 02559625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Ishihara K et al Prognostic factors for melanoma Skin Cancer, 4, 349-361, 1969.
2. Ishihara K. Clinical research into the use of human fibroblast interferon (HuIFN-β) to treat malignant skin neoplasia. J. Jpn Soc. Cancer Therapy, 18, 41-53, 1983
3. Ishihara K et al. Clinical responses of patients with malignant skin neoplasta to intralesional treatment with three types of interferons (α and β) Proceedings of the International Symposium on Interferons, October, Kyoto, Japan, 1983
4. Yamamoto A. et al On the transfer to lymph of locally injected IFN-β in malanoma melanoma patients Skin Cancer, 1, 47-53, 1986
5. Yamamoto A. et al. Perilesional injection of human interferonβ (HuIFN-β) to the primary lesion of malignant melanoma and its transfer to lymph nodes Second International Conference on Melanoma, Venice, 1989
6. Yamamoto A et al. Combination of penlesional injection of human interferon-β (HuIFN-β) with DAV chemotherapy of malignant melanoma International Conference on Biological Treatment of Melanoma and Other Cancers, Australia, 1990
7. Yamamoto A. et al Combination administration of penlesional injection of HuIFN-β in malignant melanoma. Biotherapy, 2, 173-177, 1988.
8. Yamamoto A., Mori S. Effects of combination administration of IFN-β in initial treatment of malignant melanoma Skin Cancer, 4, 8-12, 1989
9. Ishihara K , KoideT., Komatsu T Observations of antitumor action in monotherapy and combined IFN-βand DAV chemotherapy against human malignant melanoma in heterotransplantable nude mice. Skin Cancer, 6, 162-169, 1991.
10. TanakaT., Ishihara K Effects of DAV + rMuIFN-β combination therapy on mouse B16 melanoma Skin Cancer, 6, 170-173, 1991.